Nathalie Garcon
CEO
BIOASTER
Belgium
Biography
Over the past 22 years, my career has led me to roles of increasing responsibility in the management of complex multi-disciplinary projects from discovery to life cycle management of vaccines, through staffs of scientists at international levels. He have lead the design, development and implemention of GSK’s adjuvant strategy leading to the licensure of the first new adjuvanted vaccines worldwide During this period, he have built strong leadership capabilities in term of people (up to 400 scientists across 2 continents and 4 sites), general strategy definition, milestones establishment, implementation and follow up
Research Interest
He have a leading role in supporting and driving global corporate objectives, communication of ideas and their implementation, and have put in place processes and committees to ensure smooth and flawless execution of technology integration into the pipeline. Additionally, I am spokesperson for GSK vaccines for vaccines sciences and technologies.Have written over 50 scientific papers, chapters, editor of a book,and hold over 100 patents